Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Economic Study
  • Published:

Cost-effectiveness of autologous bone marrow transplantation in patients with relapsed non-Hodgkin’s lymphoma

Bone Marrow Transplantation volume 19, pages 275–281 (1997)Cite this article

Abstract

The analysis of published survival curves can be used as the basis for conducting cost-effectiveness analyses in which two treatments are compared in terms of cost per life year saved. In patients with relapsed chemosensitive non-Hodgkin’s lymphoma, autologous bone marrow transplantation (ABMT) has been reported to improve survival in comparison with control patients who receive standard chemotherapy. An incremental cost-effectiveness analysis was undertaken in which the Gompertz model was used to determine a lifetime estimate of patient-years gained by subjects given ABMT in comparison with controls. Our study utilised the cost data calculated by Uyl-de Groot et al and the clinical data reported by Philip et al. This latter randomised clinical trial involved 55 patients subjected to ABMT and 54 controls given chemotherapy. Lifetime survival advantage for patients of the ABMT group was estimated as 3606 discounted patient-months every 100 patients. The use of ABMT as opposed to standard chemotherapy was found to imply an incremental cost of $9,229 per discounted life year gained (95% CI of $5390 to $24012). The cost-effectiveness ratio of ABMT in patients with relapsed chemosensitive non-Hodgkin’s lymphoma is noticeably favourable.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Drug Information Centre, Pharmaceutical Service, Azienda Ospedaliera Careggi, Florence, Italy

    A Messori, L Bonistalli & M Costantini

  2. Department of Haematology, Azienda Ospedaliera Careggi, Florence, Italy

    R Alterini

Authors
  1. A Messori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L Bonistalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Costantini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Alterini
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Messori, A., Bonistalli, L., Costantini, M. et al. Cost-effectiveness of autologous bone marrow transplantation in patients with relapsed non-Hodgkin’s lymphoma. Bone Marrow Transplant 19, 275–281 (1997). https://doi.org/10.1038/sj.bmt.1700642

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1700642

Keywords

Search

Advanced search

Quick links